Obesity drug Wegovy cut risk of serious heart problems by 20%, study findsThe findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them. QUIZ: Lipid management made simpleThe Canadian primary-care group known as PEER (Patients, Experience, Evidence, Research) has just updated their popular 2015 guideline on prevention and management of cardiovascular disease in primary care. Test your knowledge here. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Canadian antiplatelet guidelines update: changes include no ASA for routine primary prevention of cardiac disease Other changes include recommendations for de-escalation of dual antiplatelet therapy in select patients and dual antiplatelet therapy post-CABG. Do supplements, psyllium or probiotics work to lower cholesterol? There’s some evidence that taking particular supplements, while also eating a healthy diet, can make a difference CPAP use may reduce secondary CVD events As long as people use the devices at least four hours per day. An app to save precious time during a heart attack? Developer describes technology, currently being deployed at Montreal hospitals, as the “Uber Eats of critical care.” Myocardial infarction: Aspirin reduces the risk of recurrence and death Researchers explore risks associated with stopping Aspirin long-term. Simplified Canadian lipid guidelines for primary care providers Updated evidence-based guidelines provide a simplified approach to lipid management for the prevention and management of cardiovascular disease. Cardiovascular disease in women First Previous 7 8 9 10 11 Next Last
